MedPath
HSA Approval

MEROPENEM KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 500MG/VIAL

SIN15002P

MEROPENEM KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 500MG/VIAL

MEROPENEM KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 500MG/VIAL

May 4, 2016

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI (SINGAPORE) PTE LTD

Regulatory Information

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI (SINGAPORE) PTE LTD

Therapeutic

Prescription Only

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS

Medical Information

J01DH02

meropenem

Manufacturer Information

FRESENIUS KABI (SINGAPORE) PTE LTD

ACS Dobfar S.p.A. (Primary and Secondary Packaging)

ACS DOBFAR SpA 2: Addetta Site (DP Intermediate)

Active Ingredients

Meropenem Trihydrate 570mg equivalent to anhydrous Meropenem

500mg/vial

Meropenem

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.